When Bracco introduces new customers (generators), Positron probably will be selling scanners. That means revenue. Positron will also have Strontium available in Feb. That means revenue.(In September 2013, Positron will receive relevant volumes of strontium-82 for qualification and will commence with commercial availability beginning in February 2014.) http://www.positron.com/press/post/positron-and-ithemba-labs-enters-into-radioisotope-supply-agreement
With that, Positron will look better than it did prior to the problems with Cardiogen, when they were only selling scanners.
These developments may encourage financiers to fund the cyclotron.
Institutions may not be looking at POSC now with the current state of the business and pps of .005. But, some advances are highly likely, more so than the dilution others are talking about, and an advance in pps is also likely.